Anne-Marie Leroi, Michel Queralto, Frank Zerbib, Laurent Siproudhis, Véronique Vitton, Gérard Amarenco, Isabelle Etienney, Francois Mion, Valerie Bridoux, Julie Philip, Charlène Brochard, Henri Damon, Elie Lacroix, André Gillibert, Guillaume Gourcerol
Intrarectal injections of botulinum toxin versus placebo for the treatment of urge faecal incontinence in adults (FI-Toxin): a double-blind, multicentre, randomised, controlled phase 3 study
The lancet. Gastroenterology & hepatology
analyze time first symptom treatment patients treated breast cancer public hospitals federal district crosssectional analysis interviewed 250 women diagnosed breast cancer treated six hospitals state department health federal district november 2009 january 2011 time intervals studied time detection symptoms treatment subdivided intervals first medical appointment variables age menopausal status color educational level average monthly household income origin reason initial consultation staging tumor size laterality metastasis axillary lymph nodes neoadjuvant chemotherapy type surgery mannwhtney test used assess association variables time intervals treatment mean age 52 years predominance white women 576 federal district 624 family income 2 minimum wages 78 four years schooling 524 staging disease ranged ii iv 788 women time first symptom treatment 229 days median detection first symptom 529 women attended consultation within 30 days 888 took 90 days start treatment women elementary school education greater delay start treatment p0049 significant delay start treatment women breast cancer public hospitals federal district suggesting efforts made reduce time needed schedule medical appointments diagnose treat patients